In what is considered a breakthrough of sorts, researchers believe they have zeroed in on a key protein and its presence in elevated levels in the blood of lung cancer victims. All it may take is a simple blood test to diagnose the disease.
The protein, called isocitrate dehydrogenase (IDH1), and its presence in elevated levels in the blood is the new biomarker for cancer diagnosis.
"This study is the first to report identification of IDH1 as a novel biomarker for the diagnosis of non-small ...
In what is considered a breakthrough of sorts, researchers believe they have zeroed in on a key protein and its presence in elevated levels in the blood of lung cancer victims. All it may take is a simple blood test to diagnose the disease.
The protein, called isocitrate dehydrogenase (IDH1), and its presence in elevated levels in the blood is the new biomarker for cancer diagnosis.
"This study is the first to report identification of IDH1 as a novel biomarker for the diagnosis of non-small ...